View clinical trials related to Blood Disease.
Filter by:To determine the risk factors associated with inhibitor formation in hemophilia A and to study the mechanism of tolerance in the murine hemophilia A model.
To develop a clinical severity index that could prospectively identify sickle cell disease patients who were at high risk for a turbulent clinical course and a poor prognosis.
To identify those factors that contributed to cognitive deficiencies in children with sickle cell disease (SCD) who had not demonstrated any overt or clinically apparent neurological abnormalities.
To determine if there were immune sequelae related to the long-term donation of blood or blood products.
To conduct a prospective study aimed at the early detection and treatment of cerebral vascular disease prior to irreversible brain injury in young children with sickle cell anemia (SCA).
To continue studies on the two major neurological complications of sickle cell disease (SCD): namely, stroke and chronic encephalopathy.
To examine mechanisms of individual differences in the progression of HIV infection in hemophiliacs.
To estimate the risk of death for patients with different pre- and post-operative hemoglobin levels who do not receive blood transfusions and to derive a multivariate model using clinical information available pre-operatively that would predict the risk of death post-operatively.
To quantify the role of drugs and other factors in the etiology of agranulocytosis and aplastic anemia.
To elucidate the role of hepatitis delta virus (HDV) in the development of chronic liver disease in patients with hemophilia.